hydantoins has been researched along with Pulmonary Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huaux, F; Lison, D; Uwambayinema, F; van den Brule, S; Wallemme, L | 1 |
| LOW, NL; YAHR, MD | 1 |
| Larizza, P | 1 |
3 other study(ies) available for hydantoins and Pulmonary Fibrosis
| Article | Year |
|---|---|
The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cells, Cultured; Collagen; Female; Fibroblasts; Humans; Hydantoins; Interleukin-13; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Receptors, Prostaglandin; Transforming Growth Factor beta | 2010 |
The lack of pulmonary fibrosis in patients receiving diphenylhydantoin.
Topics: Hydantoins; Phenytoin; Pulmonary Fibrosis | 1960 |
[Introduction and general data on the subject of the pathology of drugs].
Topics: Agranulocytosis; Anemia, Hemolytic; Anemia, Megaloblastic; Anemia, Sideroblastic; Bleomycin; Bone Marrow Diseases; Busulfan; Humans; Hydantoins; Iatrogenic Disease; Isoniazid; Leukopenia; Methyldopa; Pulmonary Fibrosis; Sulfonamides | 1984 |